Products

AG003OQD

Name: Cefoperazone Sodium, USP, Antibacterial.
Brand: Angene Chemical
SKU: AG003OQD

62893-20-3 | Cefoperazone Sodium, USP, Antibacterial.

Chemical structure of Cefoperazone Sodium, USP, Antibacterial., CAS 62893-20-3

AG003OQD

SDS

COA

TIP This product is typically in stock.Please contact us for quotation.

Request For Quotation

CAS Number	62893-20-3
Catalog Number	AG003OQD(AGN-PC-0T6I7G)
Chemical Name	Cefoperazone Sodium, USP, Antibacterial.
EC Number	263-751-5
IUPAC Name	sodium;(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
InChI	InChI=1S/C25H27N9O8S2.Na/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2;/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41);/q;+1/p-1/t15-,16-,22-;/m1./s1
InChI Key	NCFTXMQPRQZFMZ-WERGMSTESA-M
MDL Number	MFCD07793331
Molecular Formula	C25H26N9NaO8S2
Molecular Weight	667.6492
SMILES	O=C(C(N12)=C(CSC3=NN=NN3C)CS[C@]2([H])[C@H](NC([C@H](NC(N4C(C(N(CC)CC4)=O)=O)=O)C5=CC=C(O)C=C5)=O)C1=O)[O-].[Na+]
UNII	5FQG9774WD
Synonyms	Céfobis, Cefobid, Cefoperazon, Cefoperazone, Cefoperazone Sodium, Cefoperazone Sodium Salt, Salt, Cefoperazone Sodium, Sodium Salt, Cefoperazone, Sodium, Cefoperazone, T 1551, T-1551, T1551, CEFOPERAZONE SODIUM, 62893-20-3, Sodium cefoperazone, Cefobid, Tomabef, T-1551, CP 52640-2, Cefoperazone sodium salt, Cefoperazone (sodium salt), UNII-5FQG9774WD, CEFOBID IN PLASTIC CONTAINER, EINECS 263-751-5, T 1551, C25H26N9NaO8S2, 5FQG9774WD, CHEBI:3494, Cefobid (TN), DSSTox_CID_25874, DSSTox_RID_81192, DSSTox_GSID_45874, Sodium (6R,7R)-7-((R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-(p-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, Cefobis, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(R)))-, CAS-62893-20-3, Cefoperazin, Cefoper, MFCD07793331, Cefoperazone sodium [USAN:JAN], cefoperazon-natrium, cefoperazone-sodium, NCGC00094952-01, cefobid sodium salt, Cefoperazone sodium [USAN:USP:JAN], cefoperazone, sodium salt, SCHEMBL537680, C25H26N9O8S2.Na, CHEMBL1200482, DTXSID6045874, CTK8F8528, HY-B0210A, Cefoperazone sodium (JP17/USP), NCFTXMQPRQZFMZ-WERGMSTESA-M, 1094606-34-4, EBD47236, Tox21_111367, AKOS015951266, Tox21_111367_1, CS-5023, NCGC00179599-03, AN-39116, AB1009354, CP-526402, LS-150057, CP-52640-2, FT-0603038, CP-52,640-2, C08112, D00918, J10387, (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, [6R-[6alpha,7beta(R)]]-7-[[[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt, sodium (6R,7R)-7-((R)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, sodium (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, sodium;(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxy, cefoperazone, late, null, Cefoperazon, Sodium, Cefoperazone, SODIUM, Salt, Cefoperazone Sodium, Sodium Salt, Cefoperazone, C25H27N9O8S2.Na, CID44186, C25-H26-N9-O8-S2.Na, ACN-038392, CS-O-01069, Cefoperazone sodium salt, 98% - 1G 1g, T1551, D002438, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 62893-19-0, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R)))-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6.alpha.,7.beta.(R)]]-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6alpha,7beta(R*)]]-, CPZ,

Complexity	1250
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	3
Defined Bond Stereocenter Count	0
Exact Mass	667.124g/mol
Formal Charge	0
Heavy Atom Count	45
Hydrogen Bond Acceptor Count	13
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	667.648g/mol
Monoisotopic Mass	667.124g/mol
Rotatable Bond Count	9
Topological Polar Surface Area	274A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H317-H334
Packing Group	Ⅲ
Precautionary statements	P261-P272-P280-P285-P302+P352-P304+P341-P321-P333+P313-P342+P311-P363-P501
UN Code	UN 2811

Related Research Chemicals

CERTIFICATE OF ANALYSIS

Chemical Name:	Batch Number:
Chemical Structure:	CAS Registry No:
	Product ID:
	Manufacture Date:
	Storage Temperature:
	Formula:
	Molecular Weight:
	Quantity:

Analysis Data:

Test:

Result:

Conclusion: The above product meets the specifications of Angene.

Analyst:Chase

Date:

Reviewed by:Jessie

Date:

Angene International Limited